Goldfine, Ira D.

Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes

Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews

Advanced Glycation End Products researchNitric Oxide and Endothelin Effects

Cited by 2,232

Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction?

Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003) · Diabetes

Pancreatic function and diabetesNitric Oxide and Endothelin Effects

Cited by 1,482

The Molecular Basis for Oxidative Stress-Induced Insulin Resistance

Evans, J. L., Maddux, B. A., & Goldfine, I. D. (2005) · Antioxidants & Redox Signaling

Redox biology and oxidative stressAdipokines, Inflammation, and Metabolic Diseases

Cited by 587

Protection Against Oxidative Stress—Induced Insulin Resistance in Rat L6 Muscle Cells by Micromolar Concentrations of α-Lipoic Acid

Maddux, B. A., See, W., Lawrence, J. C., Goldfine, A. L., Goldfine, I. D., & Evans, J. L. (2001) · Diabetes

Biochemical Acid Research StudiesMetabolism, Diabetes, and Cancer

Cited by 405

Elevated insulin receptor content in human breast cancer

Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R. (1990) · Journal of Clinical Investigation

Metabolism, Diabetes, and CancerGrowth Hormone and Insulin-like Growth Factors

Cited by 338

Physiological Concentrations of Cholecystokinin Stimulate Amino Acid-Induced Insulin Release in Humans*

RUSHAKOFF, R. J., GOLDFINE, I. D., CARTER, J. D., & LIDDLE, R. A. (1987) · The Journal of Clinical Endocrinology & Metabolism

Pancreatic function and diabetesNeuropeptides and Animal Physiology

Cited by 96

Insulin Autoimmune Syndrome (Hirata Disease) in European Caucasians Taking α-Lipoic Acid

Gullo, D., Evans, J. L., Sortino, G., Goldfine, I. D., & Vigneri, R. (2014) · Clinical Endocrinology

Diabetes and associated disordersDiabetes Management and Research

Cited by 71

Reduced postprandial cholecystokinin (CCK) secretion in patients with noninsulin-dependent diabetes mellitus: evidence for a role for CCK in regulating postprandial hyperglycemia.

Rushakoff, R. A., Goldfine, I. D., Beccaria, L. J., Mathur, A., Brand, R. J., & Liddle, R. A. (1993) · The Journal of Clinical Endocrinology & Metabolism

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 59